Diruthenium Paddlewheel Complexes Attacking Proteins: Axial versus Equatorial Coordination.
anticancer metallodrugs
diruthenium paddlewheel complexes
dual drugs
protein metalation
substitution reactions
Journal
Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414
Informations de publication
Date de publication:
28 Apr 2024
28 Apr 2024
Historique:
received:
11
04
2024
revised:
25
04
2024
accepted:
26
04
2024
medline:
24
5
2024
pubmed:
24
5
2024
entrez:
24
5
2024
Statut:
epublish
Résumé
Metallodrugs are an important group of medicinal agents used for the treatment of various diseases ranging from cancers to viral, bacterial, and parasitic diseases. Their distinctive features include the availability of a metal centre, redox activity, as well as the ability to multitarget. Diruthenium paddlewheel complexes are an intensely developing group of metal scaffolds, which can securely coordinate bidentate xenobiotics and transport them to target tissues, releasing them by means of substitution reactions with biomolecular nucleophiles. It is of the utmost importance to gain a complete comprehension of which chemical reactions happen with them in physiological milieu to design novel drugs based on these bimetallic scaffolds. This review presents the data obtained in experiments and calculations, which clarify the chemistry these complexes undergo once administered in the proteic environment. This study demonstrates how diruthenium paddlewheel complexes may indeed embody a new paradigm in the design of metal-based drugs of dual-action by presenting and discussing the protein metalation by these complexes.
Identifiants
pubmed: 38785937
pii: biom14050530
doi: 10.3390/biom14050530
pii:
doi:
Substances chimiques
Coordination Complexes
0
Ruthenium
7UI0TKC3U5
Proteins
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : THE EUROPEAN UNION-NEXT-GENERATION EU
ID : PNRR M4C2-Investimento 1.4-CN00000041